Supplementary Figure S10 from Ctdna Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or Without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial
crossref(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要